No products in the cart.

Chapter 17. Drugs Affecting the Respiratory System

Pharmacotherapeutics for Advanced Practice Nurse Prescribers 4th Edition by Teri Moser Woo

$2.99

Chapter 17. Drugs Affecting the Respiratory System

 

Complete Chapter Questions With Answers

 

Sample Questions Are Posted Below

 

Identify the choice that best completes the statement or answers the question.

 

____     1.   Digoxin levels need to be monitored closely when the following medication is started:

1. Loratadine
2. Diphenhydramine
3. Ipratropium
4. Albuterol

 

 

____     2.   Patients with pheochromocytoma should avoid which of the following classes of drugs because of the possibility of developing hypertensive crisis?

1. Expectorants
2. Beta-2-agonists
3. Antitussives
4. Antihistamines

 

 

____     3.   Harold, a 42-year-old African American, has moderate persistent asthma. Which of the following asthma medications should be used cautiously, if at all?

1. Betamethasone, an inhaled corticosteroid
2. Salmeterol, an inhaled long-acting beta-agonist
3. Albuterol, a short-acting beta-agonist
4. Montelukast, a leukotriene modifier

 

 

____     4.   Long-acting beta-agonists (LTBAs) received a Black Box Warning from the U.S. Food and Drug Administration due to the:

1. Risk of life-threatening dermatological reactions
2. Increased incidence of cardiac events when LTBAs are used
3. Increased risk of asthma-related deaths when LTBAs are used
4. Risk for life-threatening alterations in electrolytes

 

Answer Section

 

MULTIPLE CHOICE

 

  1. ANS:  4                    PTS:   1

 

  1. ANS:  2                    PTS:   1

 

  1. ANS:  2                    PTS:   1

 

  1. ANS:  3                    PTS:   1

Additional information

Add Review

Your email address will not be published. Required fields are marked *